Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jürgen Alt"'
Autor:
Jong Seok Lee, François Ghiringhelli, E. Ledin, David Berz, Mark Voskoboynik, Dai Woo Kim, Nicolas Girard, C. Mascaux, Martin Wermke, Jaafar Bennouna, Arnaud Jeanson, Piotr Serwatowski, Enriqueta Felip, Björn Hackanson, Thierry Lesimple, Victoria Chen, Girish Jayadeva, Jürgen Alt, Harald Timotheus Landsteiner, Michael C. Burger
Publikováno v:
Annals of Oncology. 32:S597
Background: Combining anti-VEGF/Ang2 and anti-PD-1 therapy promotes an immunopermissive state, supportive of T-cell-mediated tumour cell destruction. This phase Ib study is assessing BI 836880 plus ezabenlimab in patients (pts) with advanced solid tu
Autor:
Harald Timotheus Landsteiner, Dong Wan Kim, Martin Wermke, François Ghiringhelli, Jong Seok Lee, Nicolas Girard, Victoria Chen, Girish Jayadeva, Fabrice Barlesi, Björn Hackanson, David Berz, Thierry Lesimple, Jaafar Bennouna, Enriqueta Felip, Jürgen Alt
Publikováno v:
Annals of Oncology. 32:S325
Autor:
Björn Hackanson, Girish Jayadeva, Harald Timotheus Landsteiner, Nicolas Girard, D-W. Kim, Fabrice Barlesi, François Ghiringhelli, Martin Wermke, Jürgen Alt
Publikováno v:
Annals of Oncology. 31:S467
Autor:
Nicolas Girard, Björn Hackanson, Fabrice Barlesi, Jürgen Alt, Girish Jayadeva, Harald Timotheus Landsteiner, Martin Wermke
Publikováno v:
Annals of Oncology. 30:v659
Background Preclinical evidence shows that vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang2) promote an immunosuppressive state in the tumour microenvironment, and that the combination of anti-VEGF/Ang2 with anti-PD-1 therapy promot
Autor:
M. Fotin-Mleczek, R. Cathomas, C. Weiss, A. Schröder, F. Griesinger, E. Niehus, M. Geißler, Alfred Zippelius, Martin Früh, Alexandros Papachristofilou, B. Scheel, H.S. Hong, Jürgen Alt, U. Klinkhardt, Ulrike Gnad-Vogt, Sven D. Koch, J. Kollmeier, Miklos Pless, Martin Sebastian, H. Bischoff, M. M. Hipp, K. J. Kallen, G. Pall, W. Hilbe, F. Doener, Thomas Wehler, T. Seibel
Publikováno v:
Cancer Immunology Research. 4:B072-B072
Background: Preclinical studies demonstrated that local radiotherapy (RT) acts synergistically with RNActive mRNA vaccines to enhance anti-tumor effects and increase tumor-infiltrating lymphocytes. BI 1361849 is a therapeutic vaccine comprising optim